Basic analysis of new evaluation method in neoadjuvant chemotherapy (Additional study of phase II trial of neoadjuvant chemotherapy for unresectable liver metastasis of colorectal cancer)
Not Applicable
- Conditions
- Colorectal cancer with unresectable liver mttastasis
- Registration Number
- JPRN-UMIN000006995
- Lead Sponsor
- Surgery, Kyorin university hospital
- Brief Summary
This clinical trial was discontinued due to a lack of case accumulation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with known severe drug hypersensitivity or drug allergies 2) Multiple primaries 3) Metastasis except for liver and regional lymph nodes 4)Infection (fever of 38 degrees C or over) 5) Severe complications (interstitial pneumonia or pulmonary fibrosis, cardiac failure, renal failure, liver failure, uncontrollable diabetes or hypertension, jaundice) 6) Pleural effusion or ascites requiring treatment 7) Diarrhea (water like) 8) During treatment of atazanavir sulfate or flucytosine 9) Pregnant women and women suspected of being pregnant and lactating woman 10) Doctor evaluate inappropriate 11) Thrombosis in arteries or veins
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study correlation with rate of tumor shrinkage by CT, rate of tumor maker decrease and CTC changes
- Secondary Outcome Measures
Name Time Method